Well-Capitalized TerrAscend Continues Targeted U.S. Strategy and Makes Progress into the Canadian Market

Exclusive meeting with TerrAscend CEO and Executive Chairman Jason Ackerman

TerrAscend (CSE: TER) (OTCQX: TRSSF) is keeping its constant strategy of pursuing a premier place in its selected markets. CEO and Executive Chairman Jason Ackerman examined in with New Cannabis Ventures to go over key U.S. areas, progress within the market that is canadian the company’s 2021 guidance. The audio of the conversation that is entire offered by the finish of the written summary.

When Ackerman spoke that is last New Cannabis Ventures, in April 2020, he was the company’s Executive Chairman and Interim CEO. He has now stepped into the CEO that is permanent role more a formality than an alteration in their day-to-day duties. During the relative head of the company, Ackerman wants to ensure that TerrAscend’s team is ahead of the growth instead of the other way around. As such, he has assessed the ongoing company’s skill and seemed for gaps that want become filled. TerrAscend has generated a culture that is strong adding new talent is a continuous evolution, according to Ackerman.

New Jersey

Late last year, TerrAscend opened a dispensary in New Jersey, and at the beginning of this year, it completed the second phase of its cultivation and manufacturing operations in the state. The market is in its infancy, but TerrAscend is positioning itself to take advantage of its opportunities.

TerrAscend Recently Completed an Expansion of its New Jersey Cultivation and Manufacturing Operations.

As an player that is early hawaii, TerrAscend should be able to start three shops, the existing restriction per operator, in front of adult-use. The business promises to be among the top players in terms of branded and manufacturing that is wholesale retail.


TerrAscend was also an entrant that is early the Pennsylvania market. This has a cultivation that is sizeable manufacturing footprint. The company represents approximately 20 percent of the supply that is wholesale forex trading, and possesses services and products in 100 % associated with the state’s dispensaries, in accordance with Ackerman.


The business is entering Maryland via an acquisition anticipated to shut within the quarter that is first giving it a footprint across three contiguous East Coast states. TerrAscend is planning to use a go-to-market that is common across those areas, developing its Apothecarium retail brand name and its own branded services and products. The business expects become a competitor that is sizeable Maryland.


On the West Coast, TerrAscend continues to make moves in the California market. The company is focused on the part that is northern of state, also it now has five shops. Additionally it is expanding the San Francisco interior grow because of its specific State Flower brand name.

The Interior of TerrAscend’s Recently Opened Berkeley Dispensary

Growth within the U.S.

As it appears to cultivate within the U.S., TerrAscend will leverage a mix of strategic M&A and growth that is organic. It is evaluating M&A opportunities, with an optical eye on areas where it may measure with restricted permit security. The business has a pipeline that is good according to Ackerman. TerrAscend will also continue to apply for licenses like it has in markets like California.

TerrAscend Plans to Continue the Growth of Its U.S. Footprint Through M&A and License Applications.

Canadian Market

The last time Ackerman spoke with New Cannabis Ventures, he acknowledged challenges in the market that is canadian. Since that time, TerrAscend has right-sized its company here, positioning it to win. It now has a very good focus that is commercial Canada, and it has pared down its SKU line to really focus on the products that are selling. A few of its SKUs have become sellers that are top Ontario as well as other provinces, in accordance with Ackerman.

CBD Possibility

TerrAscend also plays within the CBD room. Without specific shops while the license that is limited, CBD requires a different strategy than THC. With the opportunity for broad distribution and direct-to-consumer focus, CBD is a market that is good but overall, the THC marketplace is meaningfully bigger, in accordance with Ackerman.

Approach to Funding and Capital Allocation

All of TerrAscend’s expansion plans are funded, and possesses approximately $100 and $200 million excessively money designed for M&A as well as other opportunities.

The business surely could raise significantly more than C$200 million in only a days that are few. It also completed a debt deal that is significant. The capacity to raise significantly more than $300 million in money throughout the period of approximately one month signals that the areas are opening for businesses that may show strong performance that is financial according to Ackerman.

When the team is determining how to best put capital to work, it looks for the highest rates of return. Ackerman wants to see 30 to 40 percent of the ongoing company’s asset base creating high degrees of cashflow and another amount of this asset base simply starting to produce money, making a third of this asset base space for a lengthier gestation period.

2021 Guidance

TerrAscend released 2021 guidance of $360 to $380 million in web product sales and $140 to $160 million in modified EBITDA. This represents a doubling associated with the company’s top line and 3x EBITDA development, in accordance with Ackerman. Areas like nj-new jersey, Pennsylvania and Maryland will assist you to drive that growth. Proceeded traction within the market that is canadian also play a role.

Ackerman and his team track performance metrics on a weekly and basis that is monthly. The company is focusing heavily on productivity with metrics like grams per square foot on the cultivation front. The company can improve its margins by getting more yields out of its cultivation operations. TerrAscend manages its margin structure by looking for ways to decrease SG&A. Ackerman isn’t a believer that is big big overhead. A top-three or top-four player in the industry.

Coming with EBITDA margins just above 35 percent, he considers TerrAscend from the online grocery space, Ackerman is accustomed to working in a industry that is competitive. He could be TerrAscend that is positioning for now and in the long-term, as challenges like regulatory uncertainty continue to shape the cannabis business.

New Cannabis Ventures provides an Investor Dashboard for TerrAscend, which is a client of New Cannabis Ventures. Listen to the entire interview:

Get ahead of the crowd by signing up for 420 Investor, the& that is largest many comprehensive premium membership solution for cannabis traders and investors since 2013.

Carrie Pallardy, a writer that is chicago-based editor, began her career covering the healthcare industry and now writes, edits and interviews subject matter experts across multiple industries. As a published writer, Carrie continues to tell compelling, undiscovered stories to her network of readers. For more information contact us.

Get Our Newsletter(* sunday)

#mc_embed_signup{background:#fff; clear:left; }
/* include your own personal form that is mailChimp overrides in your website stylesheet or in this design block.
We suggest going this block while the CSS that is preceding link the pinnacle of the HTML file. */

Latest posts